| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Affinity assays for decrypting protein targets of unknown function
|
Todd, Matthew J.
|
|
2005
|
|
3 |
p. 267-273
7 p.
|
artikel
|
| 2 |
Analytical ultracentrifugation: a powerful ‘new’ technology in drug discovery
|
Laue, Tom
|
|
2004
|
|
3 |
p. 309-315
7 p.
|
artikel
|
| 3 |
Animal models of Alzheimer's disease and drug development
|
Laurijssens, Bart
|
|
2013
|
|
3 |
p. e319-e327
nvt p.
|
artikel
|
| 4 |
Applying chemical tools to the discovery of novel regenerative medicine
|
Wu, Tom Y.H.
|
|
2006
|
|
3 |
p. 255-260
6 p.
|
artikel
|
| 5 |
Automation of decision making in drug design
|
Leahy, David E.
|
|
2013
|
|
3 |
p. e437-e441
nvt p.
|
artikel
|
| 6 |
Bridging the gap in the fight against tuberculosis
|
Davies, G.R.
|
|
2013
|
|
3 |
p. e359-e364
nvt p.
|
artikel
|
| 7 |
Combination of ligand- and structure-based methods in virtual screening
|
Drwal, Malgorzata N.
|
|
2013
|
|
3 |
p. e395-e401
nvt p.
|
artikel
|
| 8 |
Combined quantum and molecular mechanics (QM/MM)
|
Friesner, Richard A.
|
|
2004
|
|
3 |
p. 253-260
8 p.
|
artikel
|
| 9 |
Competitive intelligence and patent analysis in drug discovery
|
Grandjean, Nicolas
|
|
2005
|
|
3 |
p. 211-215
5 p.
|
artikel
|
| 10 |
Contents
|
|
|
2004
|
|
3 |
p. i-
1 p.
|
artikel
|
| 11 |
Contents
|
|
|
2013
|
|
3 |
p. i-ii
nvt p.
|
artikel
|
| 12 |
Data-driven computer aided synthesis design
|
Ravitz, Orr
|
|
2013
|
|
3 |
p. e443-e449
nvt p.
|
artikel
|
| 13 |
De novo computer-aided design of novel antiviral agents
|
Massarotti, Alberto
|
|
2012
|
|
3 |
p. e213-e218
nvt p.
|
artikel
|
| 14 |
Determination of absolute configuration via vibrational circular dichroism
|
Kuppens, Tom
|
|
2004
|
|
3 |
p. 269-275
7 p.
|
artikel
|
| 15 |
Difference gel electrophoresis DIGE
|
Lilley, Kathryn S
|
|
2006
|
|
3 |
p. 347-353
7 p.
|
artikel
|
| 16 |
Drug-like properties: guiding principles for design – or chemical prejudice?
|
Leeson, Paul D.
|
|
2004
|
|
3 |
p. 189-195
7 p.
|
artikel
|
| 17 |
Editorial
|
|
|
2005
|
|
3 |
p. 193-195
3 p.
|
artikel
|
| 18 |
Editorial
|
Herdewijn, Piet
|
|
2012
|
|
3 |
p. e175-e176
nvt p.
|
artikel
|
| 19 |
Essential enrichment strategies in phosphoproteomics
|
Pinkse, Martijn W.H.
|
|
2006
|
|
3 |
p. 331-337
7 p.
|
artikel
|
| 20 |
Establishing in vitro to clinical correlations in the evaluation of cardiovascular safety pharmacology
|
Chain, A.S.Y.
|
|
2013
|
|
3 |
p. e373-e383
nvt p.
|
artikel
|
| 21 |
Evaluation of symptomatic drug effects in Alzheimer's disease: strategies for prediction of efficacy in humans
|
Deguil, J.
|
|
2013
|
|
3 |
p. e329-e342
nvt p.
|
artikel
|
| 22 |
Expanding the frontiers in proteomics
|
Gavin, Anne-Claude
|
|
2006
|
|
3 |
p. 315-316
2 p.
|
artikel
|
| 23 |
Exploiting new approaches for natural product drug discovery in the biotechnology industry
|
Gullo, Vincent P.
|
|
2005
|
|
3 |
p. 281-286
6 p.
|
artikel
|
| 24 |
Fast similarity searching and screening hit analysis
|
Baringhaus, Karl-Heinz
|
|
2004
|
|
3 |
p. 197-202
6 p.
|
artikel
|
| 25 |
Fragment library design: efficiently hunting drugs in chemical space
|
Boyd, Susan M.
|
|
2010
|
|
3 |
p. e173-e180
nvt p.
|
artikel
|
| 26 |
Fragments: past, present and future
|
Whittaker, Mark
|
|
2010
|
|
3 |
p. e163-e171
nvt p.
|
artikel
|
| 27 |
Fueling HIV-1 integrase drug design with structural insights
|
Demeulemeester, Jonas
|
|
2012
|
|
3 |
p. e205-e212
nvt p.
|
artikel
|
| 28 |
High throughput, nanoliter quantitative PCR
|
Brenan, Colin
|
|
2005
|
|
3 |
p. 247-253
7 p.
|
artikel
|
| 29 |
Human aspects of the management of drug discovery knowledge
|
Davenport, Thomas H.
|
|
2005
|
|
3 |
p. 205-209
5 p.
|
artikel
|
| 30 |
Humanised models of infection in the evaluation of anti-malarial drugs
|
Angulo-Barturen, Iñigo
|
|
2013
|
|
3 |
p. e351-e357
nvt p.
|
artikel
|
| 31 |
Induced fit docking, and the use of QM/MM methods in docking
|
Xu, Mengang
|
|
2013
|
|
3 |
p. e411-e418
nvt p.
|
artikel
|
| 32 |
Informatics, docking and data investigation
|
Green, Darren V.S.
|
|
2013
|
|
3 |
p. e385-e386
nvt p.
|
artikel
|
| 33 |
Information extraction technologies for the life science industry
|
Fluck, Juliane
|
|
2005
|
|
3 |
p. 217-224
8 p.
|
artikel
|
| 34 |
In silico antitarget screening
|
Recanatini, Maurizio
|
|
2004
|
|
3 |
p. 209-215
7 p.
|
artikel
|
| 35 |
In silico docking and scoring of fragments
|
Chen, Yu
|
|
2010
|
|
3 |
p. e149-e156
nvt p.
|
artikel
|
| 36 |
In silico virtual screening approaches for anti-viral drug discovery
|
Murgueitio, Manuela S.
|
|
2012
|
|
3 |
p. e219-e225
nvt p.
|
artikel
|
| 37 |
In vitro combinatorial chemistry to create drug candidates
|
Weber, Lutz
|
|
2004
|
|
3 |
p. 261-267
7 p.
|
artikel
|
| 38 |
Isothermal titration calorimetry: controlling binding forces in lead optimization
|
Freire, Ernesto
|
|
2004
|
|
3 |
p. 295-299
5 p.
|
artikel
|
| 39 |
Large-scale SAR analysis
|
Bajorath, Jürgen
|
|
2013
|
|
3 |
p. e419-e426
nvt p.
|
artikel
|
| 40 |
Lead identification in post-genomics: computers as a complementary alternative
|
Klebe, Gerhard
|
|
2004
|
|
3 |
p. 225-230
6 p.
|
artikel
|
| 41 |
Ligand efficiency as a guide in fragment hit selection and optimization
|
Schultes, Sabine
|
|
2010
|
|
3 |
p. e157-e162
nvt p.
|
artikel
|
| 42 |
Locked nucleic acid (LNA): High affinity targeting of RNA for diagnostics and therapeutics
|
Kauppinen, Sakari
|
|
2005
|
|
3 |
p. 287-290
4 p.
|
artikel
|
| 43 |
Managing genomic and proteomic knowledge
|
Lutz, Michael W.
|
|
2005
|
|
3 |
p. 197-204
8 p.
|
artikel
|
| 44 |
Medicinal chemistry
|
Zhang, Li-he
|
|
2006
|
|
3 |
p. 239-240
2 p.
|
artikel
|
| 45 |
Modeling of human tumor xenografts and dose rationale in oncology
|
Simeoni, Monica
|
|
2013
|
|
3 |
p. e365-e372
nvt p.
|
artikel
|
| 46 |
Multi-objective optimization methods in drug design
|
Nicolaou, Christos A.
|
|
2013
|
|
3 |
p. e427-e435
nvt p.
|
artikel
|
| 47 |
New approaches for NMR screening in drug discovery
|
Fernández, César
|
|
2004
|
|
3 |
p. 277-283
7 p.
|
artikel
|
| 48 |
New concepts and approaches for drug discovery based on traditional Chinese medicine
|
Xu, Xiaojie
|
|
2006
|
|
3 |
p. 247-253
7 p.
|
artikel
|
| 49 |
New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery
|
Tang, Yun
|
|
2006
|
|
3 |
p. 307-313
7 p.
|
artikel
|
| 50 |
New trends in carbohydrate-based vaccines
|
Roy, René
|
|
2004
|
|
3 |
p. 327-336
10 p.
|
artikel
|
| 51 |
Next generation sequencing technologies
|
Jarvie, Thomas
|
|
2005
|
|
3 |
p. 255-260
6 p.
|
artikel
|
| 52 |
Ontologies in drug discovery
|
Gardner, Stephen P.
|
|
2005
|
|
3 |
p. 235-240
6 p.
|
artikel
|
| 53 |
Optimization algorithms and natural computing in drug discovery
|
Solmajer, Tom
|
|
2004
|
|
3 |
p. 247-252
6 p.
|
artikel
|
| 54 |
Pharmacophore definition and 3D searches
|
Langer, T.
|
|
2004
|
|
3 |
p. 203-207
5 p.
|
artikel
|
| 55 |
Phospho-specific flow cytometry in drug discovery
|
Clutter, Matthew R.
|
|
2005
|
|
3 |
p. 295-302
8 p.
|
artikel
|
| 56 |
Practical considerations for developing nucleoside reverse transcriptase inhibitors
|
Hurwitz, Selwyn J.
|
|
2012
|
|
3 |
p. e183-e193
nvt p.
|
artikel
|
| 57 |
Profiling molecular interactions using label-free acoustic screening
|
Cooper, Matthew A.
|
|
2005
|
|
3 |
p. 241-245
5 p.
|
artikel
|
| 58 |
Profiling the kinome for drug discovery
|
Yan, S. Frank
|
|
2006
|
|
3 |
p. 269-276
8 p.
|
artikel
|
| 59 |
Progress in combinatorial biosynthesis for drug discovery
|
Van Lanen, Steven G.
|
|
2006
|
|
3 |
p. 285-292
8 p.
|
artikel
|
| 60 |
Protein co-membership and biochemical affinity purifications
|
Gavin, Anne-Claude
|
|
2006
|
|
3 |
p. 325-330
6 p.
|
artikel
|
| 61 |
Proteome-scale docking: myth and reality
|
Rognan, Didier
|
|
2013
|
|
3 |
p. e403-e409
nvt p.
|
artikel
|
| 62 |
Proteomic analysis of GPI-anchored membrane proteins
|
Jung, Hye Ryung
|
|
2006
|
|
3 |
p. 339-346
8 p.
|
artikel
|
| 63 |
Recent advances in microarrays
|
Dill, Kilian
|
|
2005
|
|
3 |
p. 261-266
6 p.
|
artikel
|
| 64 |
Recent development of RNAi in drug target discovery and validation
|
Liu, Guohong
|
|
2006
|
|
3 |
p. 293-300
8 p.
|
artikel
|
| 65 |
Scaffold hopping
|
Böhm, Hans-Joachim
|
|
2004
|
|
3 |
p. 217-224
8 p.
|
artikel
|
| 66 |
Scoring functions for protein–ligand interactions: a critical perspective
|
Schulz-Gasch, Tanja
|
|
2004
|
|
3 |
p. 231-239
9 p.
|
artikel
|
| 67 |
Serendipity and VZV drug discovery
|
Derudas, Marco
|
|
2012
|
|
3 |
p. e177-e181
nvt p.
|
artikel
|
| 68 |
Single molecule technologies
|
Rooke, Jenny E.
|
|
2005
|
|
3 |
p. 275-280
6 p.
|
artikel
|
| 69 |
Slow-MAS NMR: A new technology for in vivo metabolomic studies
|
Wind, Robert A.
|
|
2005
|
|
3 |
p. 291-294
4 p.
|
artikel
|
| 70 |
Structural biology of the hepatitis C virus proteins
|
Weiser, Briana M.
|
|
2012
|
|
3 |
p. e195-e204
nvt p.
|
artikel
|
| 71 |
Structure-based drug design: NMR-based approach for ligand–protein interactions
|
Zhang, Xu
|
|
2006
|
|
3 |
p. 241-245
5 p.
|
artikel
|
| 72 |
Surface Plasmon Resonance biosensor analysis as a useful tool in FBDD
|
Retra, Kim
|
|
2010
|
|
3 |
p. e181-e187
nvt p.
|
artikel
|
| 73 |
Targeting transcription factors in cancer: Challenges and evolving strategies
|
Redell, Michele S.
|
|
2006
|
|
3 |
p. 261-267
7 p.
|
artikel
|
| 74 |
Techniques used for the discovery of therapeutic compounds: The case of SARS
|
Chen, Shuai
|
|
2006
|
|
3 |
p. 277-283
7 p.
|
artikel
|
| 75 |
Technologies: preclinical imaging for drug development
|
Matthews, Paul M.
|
|
2013
|
|
3 |
p. e343-e350
nvt p.
|
artikel
|
| 76 |
The heat is on: thermodynamic analysis in fragment-based drug discovery
|
Edink, Ewald
|
|
2010
|
|
3 |
p. e189-e201
nvt p.
|
artikel
|
| 77 |
The HTS dogma is shattered, and now there are fragments everywhere
|
de Esch, Iwan J.P.
|
|
2010
|
|
3 |
p. e147-e148
nvt p.
|
artikel
|
| 78 |
The potential of metabonomics in drug safety and toxicology
|
Griffin, Julian L.
|
|
2004
|
|
3 |
p. 285-293
9 p.
|
artikel
|
| 79 |
The Semantic Web and Knowledge Grids
|
Goble, Carole
|
|
2005
|
|
3 |
p. 225-233
9 p.
|
artikel
|
| 80 |
The synthesis of well-defined heparin and heparan sulfate fragments
|
Codée, Jeroen D.C.
|
|
2004
|
|
3 |
p. 317-326
10 p.
|
artikel
|
| 81 |
Translational pharmacology: from animal to man and back
|
Della Pasqua, Oscar
|
|
2013
|
|
3 |
p. e315-e317
nvt p.
|
artikel
|
| 82 |
Two-hybrid and its recent adaptations
|
Lievens, Sam
|
|
2006
|
|
3 |
p. 317-324
8 p.
|
artikel
|
| 83 |
Use of high-throughput LC–MS/MS proteomics technologies in drug discovery
|
Shen, Zhouxin
|
|
2006
|
|
3 |
p. 301-306
6 p.
|
artikel
|
| 84 |
Using 3D protein structures to derive 3D-QSARs
|
Wade, Rebecca C.
|
|
2004
|
|
3 |
p. 241-246
6 p.
|
artikel
|
| 85 |
Very large virtual compound spaces: construction, storage and utility in drug discovery
|
Peng, Zhengwei
|
|
2013
|
|
3 |
p. e387-e394
nvt p.
|
artikel
|
| 86 |
Why you should be using more SPR biosensor technology
|
Rich, Rebecca L.
|
|
2004
|
|
3 |
p. 301-308
8 p.
|
artikel
|
Tijdschrift beschrijving